If you’re big pharma and haven’t spent the last 10 years developing regen therapies and running trials, then your only way in when the FDA turn the tap on is to buy your way in. FDA fast track approval on CHF, CLBP or RA for MSB will necessitate a really big deal or MSB can just go it alone knowing the revenues are assured. Win win.
If you’re big pharma and haven’t spent the last 10 years...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |